Insmed Inc (INSM)

[wjlknew]

I read the opt-in period the same way, and that applies to ALL Iplex indications does it not (including ALS and diabetes)? It appears to me that INSM is allowed to develop Iplex up to phase III for any indication other than short stature (at their own expense of course) and then is relegated to a back seat role with a royalty if the indication looks promising and either DNA or TRCA opt-in. In other words, INSM can never be more than a silent partner and already has all the partners they will probably ever have ... so long as the subject patents are in force. I suppose a thrid party could partner with INSM if DNA and TRCA choose not to opt-in, but why would they?

I guess that's what happens when you willfully infringe someone elses patents. It also explains the current pps.